Sec Form 4 Filing - DENT MICHAEL T @ HealthLynked Corp - 2023-12-01

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person DENT MICHAEL T 2. Issuer Name and Ticker or Trading Symbol HealthLynked Corp [ HLYK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 1265 CREEKSIDE PKWY,, SUITE 302 3. Date of Earliest Transaction (MM/DD/YY) 12/01/2023 (Street) NAPLES, FL34108 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant $ 0.06 12/01/2023 J( 1 ) 1,500,000 12/01/2023 11/30/2028 Common stock 1,500,000 $ 0 ( 1 ) 1,500,000 I Held by Trust ( 2 ) 12% Convertible Notes $ 0.0573 03/27/2024 J( 3 ) 03/27/2024 08/24/2024 Common stock 2,617,801 $ 150,000 ( 4 ) $ 150,000 I Held by Trust ( 2 ) 12% Convertible Notes $ 0.0573 03/27/2024 J( 3 ) 03/27/2024 06/27/2024 Common stock 6,108,202 $ 350,000 ( 4 ) $ 350,000 I Held by Trust ( 2 ) 12% Convertible Notes $ 0.0573 03/27/2024 J( 3 ) 03/27/2024 08/28/2024 Common stock 2,905,759 $ 166,500 ( 4 ) ( 5 ) $ 166,500 I Held by Trust ( 2 ) Warrant $ 0.06 03/29/2024 J( 6 ) 6,660,000 03/29/2024 03/28/2034 Common stock 6,660,000 $ 0 ( 6 ) 6,660,000 I Held by Trust ( 2 ) Employee stock option $ 0.0569 03/29/2024 A 1,600,000 ( 7 ) 03/28/2034 Common stock 1,600,000 $ 0 1,600,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other DENT MICHAEL T 1265 CREEKSIDE PKWY, SUITE 302 NAPLES, FL34108 X X Chief Executive Officer Signatures /s/ Michael Dent 04/04/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The reporting person's trust received warrants to purchase shares of Issuer's common stock as warrant coverage in connection with the purchase of an unsecured promissory note with a face value of $150,000 from the Issuer on the transaction date. ( 2 )Held beneficially by the Mary S. Dent Gifting Trust dated January 31, 2006. The reporting person is the trustee of such trust. ( 3 )The reporting person's trust purchased this convertible note from the Issuer. ( 4 )Excludes shares issuable at the election of the reporting person upon conversion of accrued interest into shares of common stock. ( 5 )The reporting person's trust was issued a 12% Convertible Note in the principal amount of $166,500 in exchange for an unsecured promissory note in the principal amount of $166,500 previously issued to the reporting person's trust. ( 6 )The reporting person's trust received the warrants to purchase shares of Issuer's common stock as warrant coverage in connection with the issuance of the three convertible notes reported on this Table II. ( 7 )The option vesting schedule is: 900,000 shares upon grant, 150,000 shares on July 31, 2024, 200,000 shares on March 29, 2025, 150,000 shares on July 31, 2025 and 200,000 shares on March 29, 2026.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.